GHK-Cu
GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide that declines markedly in the body with age. Research demonstrates it stimulates collagen and elastin synthesis in human dermal cells, reduces matrix metalloproteinase activity that degrades existing skin proteins, and modulates thousands of genes involved in tissue repair and antioxidant defence. Human skin biopsy studies confirmed increased dermal collagen density, improved skin firmness and reduced fine line depth in treated participants.
Supplied as research-grade lyophilised peptide. Available in vial and pre-filled pen formats. For research purposes only.
Research Stack Builder
Build Your Research Stack
Curated combinations based on what researchers actually stack — backed by published data, priced to save.
Stack with GHK-Cu
Why researchers stack these
- 01Collagen, antioxidant & cellular energy combined
- 02NAD+ fuels collagen synthesis demands
- 03Top 3 longevity compounds on Peptide Pal
Full research context
GHK-Cu stimulates collagen synthesis, drives angiogenesis, and modulates over 4,000 genes including broad repair pathway upregulation and inflammatory downregulation. Glutathione provides the antioxidant complement — reducing the systemic oxidative stress that impairs the gene regulation GHK-Cu drives; clinical trials demonstrate 30–35% increases in tissue GSH levels. NAD+ and MOTS-c provide the cellular energy substrate: the gene modulation and collagen synthesis that GHK-Cu drives are metabolically costly, and researchers consistently add NAD+ to sustain those processes.
Recovery & Repair Protocol
The most studied peptide combination for tissue repair, injury recovery & musculoskeletal healing
Why researchers stack these
- 01Non-competing structural repair pathways
- 02BPC-157 angiogenesis + TB-500 satellite cell activation
- 03GHK-Cu adds the extracellular matrix layer both lack
Full research context
BPC-157 and TB-500 are the two most frequently co-researched repair peptides in published literature, acting through complementary mechanisms — BPC-157 via nitric oxide pathways and angiogenesis, TB-500 via actin-sequestering and satellite cell activation. GHK-Cu rounds out the stack by supporting collagen synthesis and the extracellular matrix that both compounds do not directly address, while reducing the oxidative load that slows tissue recovery.
Metabolic & Body Recomposition
Most popular Peptide Pal stack — two non-competing fat loss axes with skin integrity support
Why researchers stack these
- 01GLP-1 triple agonism + GH axis — two distinct fat loss pathways
- 02Skin integrity preserved throughout recomposition
- 03Most purchased together on Peptide Pal
Full research context
Retatrutide and Tesamorelin address body composition through two non-competing mechanisms. Retatrutide's triple receptor agonism drives broad metabolic improvement and appetite regulation; Tesamorelin is FDA-approved for visceral adipose reduction through the growth hormone axis — a distinct mechanism. GHK-Cu supports skin integrity during recomposition; rapid fat loss without collagen support produces visible skin laxity that is far harder to address after the fact.
Cognitive Performance Stack
Neuropeptides studied for synergistic cognitive enhancement, focus & stress resilience — no sedation
Why researchers stack these
- 01BDNF stimulation balanced by GABA modulation
- 02Focus without anxiety — three non-competing pathways
- 03NAD+ fuels the neuronal energy demand
Full research context
Semax and Selank are registered pharmaceuticals with distinct mechanisms. Semax drives BDNF upregulation and cortical processing speed; Selank reduces the stress-induced cognitive interference that can blunt that effect, without sedation or dependency. NAD+ provides the cellular energy substrate that enhanced neuronal activity demands — researchers consistently report that this combination delivers balanced cognitive performance that neither compound achieves alone.
Skin & Glow Protocol
Collagen synthesis, antioxidant protection & melanin research in one comprehensive skin stack
Why researchers stack these
- 01Collagen, antioxidant & pigmentation — three skin pillars
- 02Tyrosinase inhibition counterbalances MC1R agonism for pathway research
- 03Structural integrity maintained alongside brightening
Full research context
GHK-Cu stimulates collagen synthesis and modulates over 4,000 genes involved in skin repair and inflammatory control — addressing the structural layer. Glutathione reduces oxidative stress and inhibits tyrosinase, producing measurable skin brightening with 30–35% tissue GSH increases confirmed in human RCTs. MT2 drives eumelanin synthesis via MC1R agonism, and researchers frequently combine it with Glutathione to study the interplay between melanocortin-driven pigmentation and tyrosinase inhibition simultaneously. Together these three represent the most comprehensive skin research protocol available.
Cellular Longevity Protocol
Three compounds that decline together with age — combined restoration for mitochondrial & cellular health
Why researchers stack these
- 01All three decline together with age — parallel restoration
- 02Mitochondrial energy, AMPK signalling & antioxidant protection
- 03Most complete cellular longevity protocol available
Full research context
NAD+, MOTS-c, and glutathione all decline measurably with age through parallel but distinct pathways. NAD+ restores sirtuin and PARP function essential for mitochondrial biogenesis and DNA repair — declining up to 50% by age 60. MOTS-c is the mitochondria-derived peptide that activates AMPK signalling and declines alongside NAD+; their combined restoration is the most researched longevity intervention. Glutathione provides the antioxidant protection that prevents cellular damage during the heightened metabolic activity that NAD+ and MOTS-c restoration drives — completing what researchers describe as the foundational cellular longevity triad.
Research & Studies
Peer-reviewed research supporting GHK-Cu
GHK-Cu Improves Collagen Density and Reduces Wrinkle Depth in Clinical Study of Human Skin
Clinical and ex vivo evaluation of GHK-Cu on human skin demonstrated that treatment significantly increased type I and type III collagen gene expression, stimulated proteoglycan synthesis, and promoted dermal tissue remodelling. Skin biopsies from treated areas showed measurably increased dermal collagen density and improved extracellular matrix organisation, accompanied by reductions in matrix metalloproteinase (MMP) activity. In participants with photoaged skin, significant improvements in skin thickness, firmness, and fine line depth were recorded, translating the mechanistic TGF-β pathway findings into direct clinical evidence of GHK-Cu efficacy in restoring skin architecture and integrity.
GHK-Cu: Collagen Synthesis Stimulation, Antioxidant Activity and Tissue Remodelling
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide that stimulates collagen and glycosaminoglycan synthesis in dermal fibroblasts through activation of TGF-β signalling pathways. Research confirms potent antioxidant activity, promotion of angiogenesis, and the ability to modulate over 4,000 human genes — including upregulation of tissue repair pathways and downregulation of inflammatory and cancer-associated gene networks. GHK-Cu levels naturally decline with age, falling approximately 1,000-fold between ages 20 and 60, and restoration has been associated with significant improvements in wound healing speed, skin thickness, and dermal density.